GONAL-F

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug GONAL-F contains one active pharmaceutical ingredient (API):

1 Follitropin alfa UNII 076WHW89TW - FOLLITROPIN

In women, the most important effect resulting from parenteral administration of FSH is the development of mature Graafian follicles. Read about Follitropin alfa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03GA05	Follitropin alfa	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 6431L, 6432M, 6433N, 8713N, 8714P, 8715Q
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525413010043803, 525413010043903, 525413010044003, 525421301152414
Country: CA	Health Products and Food Branch	Identifier(s): 02248154, 02270382, 02270390, 02270404
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 26.611-09-05
Country: EE	Ravimiamet	Identifier(s): 1035784, 1063886, 1107403, 1107414, 1173855, 1173866, 1207864, 1213513, 1217045, 1833993
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 95001021, 95001025, 95001027, 95001033, 95001034, 95001035, 95001036
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 010102, 016892, 016927, 016938, 483844
Country: FR	Base de données publique des médicaments	Identifier(s): 60749100, 62483399, 65329591, 65913137, 67112526
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 311260, 311262, 311266, 45254, 45258, 46344
Country: HK	Department of Health Drug Office	Identifier(s): 41249, 49109, 51484, 53414, 53415, 53416
Country: IE	Health Products Regulatory Authority	Identifier(s): 88465, 88468, 88469, 88470, 88471, 88485
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6542, 6543, 6544
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1011802, 1012596, 1012597, 1012598, 1015881, 1028627, 1028628, 1028629, 1028633, 1089412
Country: NL	Z-Index G-Standaard	Identifier(s): 14805200, 14806746, 14808447, 15008355, 15008371, 15092399
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 117528, 117536, 117544, 67458, 67466, 67474
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10779, 10780, 10781, 11567, 8497, 9908
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100091488, 100126809, 100126815, 100126821, 100126838, 100126844, 100126850, 100448424
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65133001, W65133002, W65133003, W65133004, W65134001, W65134002, W65135001, W65135002, W65136001, W65136002
Country: SG	Health Sciences Authority	Identifier(s): 11779P, 12450P, 13022P, 13023P, 13024P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 22073011, 22073012, 22073013, 4703011, 4703012, 4703031
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699777790119, 8699777790126, 8699777790133, 8699777790140, 8699777790157, 8699777950278, 8699777950285, 8699777950292
Country: US	FDA, National Drug Code	Identifier(s): 44087-1115, 44087-1116, 44087-1117
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/21.10/0522, 36/21.10/0307